PHARMACHEM MELOXIVET

País: Australia

Idioma: inglés

Fuente: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredientes activos:

MELOXICAM

Disponible desde:

BOCKO P/L & FLEXSKY P/L (IN PARTNERSHIP) T/A PHARMACHEM

clase:

VetChem

Grupo terapéutico:

DOG | BITCH | CASTRATE | PUPPY

Área terapéutica:

MUSCULOSKELETAL SYSTEM

indicaciones terapéuticas:

MUSCOSKELETAL DISCOMFORT | INFLAMMATION | PAIN

Estado de Autorización:

Registered

Fecha de autorización:

2010-05-31

Información para el usuario

ACTIVE CONSTITUENT
1.5mg/mL MELOXICAM
AN ORAL SUSPENSION FOR THE
ALLEVIATION OF INFLAMMATION 
AND PAIN IN BOTH ACUTE
AND CHRONIC MUSCULOSKELETAL 
DISORDERS IN DOGS
AN ORAL SUSPENSION FOR THE
ALLEVIATION OF INFLAMMATION 
AND PAIN IN BOTH ACUTE
AND CHRONIC MUSCULOSKELETAL 
DISORDERS IN DOGS
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
MELOXIVET
PHARMACHEM
MELOXIVET
10ML
ACTIVE CONSTITUENT
1.5mg/mL MELOXICAM
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
MELOXIVET
PHARMACHEM
MELOXIVET
10ML
MELOXIVET
PHARMACHEM
MELOXIVET
FIRST AID:
If poisoning occurs, contact a doctor
or Poisons Information Centre.
Phone Australia 131126
Dispose of empty container by
wrapping in paper and placing
in garbage.
Store below 25°C (air conditioning).
APVMA Approval No.: 
64854/10mL/0310
READ THE ENCLOSED
LEAFLET BEFORE USING
THIS PRODUCT
DIRECTIONS FOR USE:
SHAKE WELL BEFORE USE
Discard six months after initial
use when stored below
25°C (air conditioning).
DOSAGE:
Initial dose:
0.2mg/kg bodyweight
2 drops/kg or 1mL/7.5kg
Maintenance Dose:
0.1mg/kg bodyweight
1 drop/kg or 1mL/15kg
6/70 Fison Avenue West
Eagle Farm QLD 4009
AN ORAL SUSPENSION FOR THE ALLEVIATION
OF INFLAMMATION AND PAIN IN BOTH ACUTE
AND CHRONIC MUSCULOSKELETAL 
DISORDERS IN DOGS
C06450
File: 64854-49442-10mL-Carton-MPL-V1
Size:  38mm x 35mm x 98mm high @70% scale at A4
Date: 28/04/2010

APPROVED 
LABEL 

Info

PEST

Verified

PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
MELOXIVET
PHARMACHEM
MELOXIVET
10ML
ACTIVE CONSTITUENT 
1.5mg/mL MELOXICAM
An oral suspension for the alleviation of 
inflammation and pain in both acute and
chronic musculoskeletal disorders in dogs
READ THE ENCLOSED LEAFLET BEFORE
USING THIS PRODUCT
DIRECTIONS FOR USE:
SHAKE WELL BEFORE USE 
Discard six months after initial use when stored below
25°C (air conditioning).
STORE below 25°C (air conditioning).
APVMA Approval No.: 64854/

Ficha técnica

DATE OF ISSUE: OCTOBER, 2007 

MATERIAL SAFETY DATA SHEET 

PHARMACHEM MELOXIVET ANTI-INFLAMMATORY ORAL SUSPENSION FOR DOGS 

Page 1 of 9 
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) 
SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY 
PHARMACHEM  

ABN: 57 147 389 678 
TEL: [phone] 
UNIT 6, 70 FISON AVE WEST 

FAX: [phone] 
EAGLE FARM QLD 4009 

SUBSTANCE:   

Water solution/suspension of ingredients. 
TRADE NAME:  
PHARMACHEM MELOXIVET ANTI-INFLAMMATORY ORAL SUSPENSION FOR DOGS 
APVMA CODE:  

50436 
PRODUCT USE:  
For the alleviation of inflammation and pain in both acute and chronic 
musculoskeletal disorders in dogs. 

CREATION DATE:  

OCTOBER, 2007 
REVISION DATE:  

AUGUST, 2010 

SECTION 2 - HAZARDS IDENTIFICATION 
STATEMENT OF HAZARDOUS NATURE 
This product is classified as: Not classified as hazardous according to the criteria of ASCC. 
Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. 
RISK PHRASES:  

Not Hazardous - No criteria found. 
SAFETY PHRASES:    
S25. Avoid contact with eyes. 
SUSDP CLASSIFICATION:   S4 
ADG CLASSIFICATION:  
None allocated. Not a Dangerous Good under the ADG Code. 
UN NUMBER:  

None allocated 
EMERGENCY OVERVIEW 
PHYSICAL DESCRIPTION & COLOUR: White viscous liquid. 
ODOUR:  

Mild odour. 
MAJOR HEALTH HAZARDS:   no significant risk factors have been found for this product. 

DATE OF ISSUE: OCTOBER, 2007 

MATERIAL SAFETY DATA SHEET 

PHARMACHEM MELOXIVET ANTI-INFLAMMATORY ORAL SUSPENSION FOR DOGS 

Page 2 of 9 
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) 
POTENTIAL HEALTH EFFECTS 

I